Smith & Nephew Inc. Acquires Privately-Held TENET Medical Engineering, Inc.; Premier Provider of Surgical Patient Positioning Equipment



ANDOVER, Mass., June 23, 2011 /CNW/ -- Smith & Nephew, (NYSE: SNN; LSE: SN), on behalf of its Endoscopy Division announced today the acquisition of privately-held, Calgary, Alberta-based TENET Medical Engineering, Inc.

TENET markets leading edge technology in the area of patient positioning such as intuitive positioning controls, increased versatility, adjustability and stability, global compatibility and fully integrated systems used in arthroscopic surgery.

TENET's products are complementary to Smith & Nephew's existing comprehensive arthroscopy portfolio and will be sold through Smith & Nephew Endoscopy's global sales team. Prior to the acquisition, Smith & Nephew Endoscopy had a long-standing distribution agreement in place to be the distributor of choice for TENET's patient positioning products.

"TENET is well known as the premier provider of patient positioning systems to surgeons and medical facilities around the world," commented Mike Frazzette, president, Smith & Nephew Endoscopy. "TENET also brings considerable material expertise and a global awareness of customer needs, all of which complements Smith & Nephew's own deep understanding of arthroscopic procedures and techniques."


    Terms of the agreement were not disclosed.

    About Smith & Nephew

Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy, including Sports Medicine; and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2010 were nearly $4.0 billion.


    Forward-Looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions and our success in integrating acquired businesses; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.

Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

    Contact:  Media
              Joe Metzger
              SVP, Corporate Communications
              Smith & Nephew Endoscopy
              (978) 749-1330 (office)
              (978) 273-5187 (cell)

              Investor/Analyst Phil Cowdy
              Head of Corporate Affairs
              Smith & Nephew
                                            44 (0)20 7401 7646



For further information: Web Site:

Profil de l'entreprise

Smith & Nephew

Renseignements sur cet organisme


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.